Assignee
WUGEN INC
US·0 granted patents·9 pending applications·0 citations·filing 2019–2024
Top patents by PatentIndex Score
9 records- 0169US2024374639A1Expansion of memory natural killer cellsWUGEN INC·Filed 2024·Application pending·0 cites
- 0266US2024189355A1Hypoimmunogenic cells having targeted modifications in mhc class-i genes and methods of useWUGEN INC·Filed 2023·Application pending·0 cites
- 0365US2024173407A1Generation of cd3 expressing immune cells for use in conjunction with cd3 binding bispecific targeting agentsWUGEN INC·Filed 2023·Application pending·0 cites
- 0464US2024358759A1Combination cancer therapy with memory nk cells and anti-cancer bispecific moleculesWUGEN INC·Filed 2024·Application pending·0 cites
- 0564US2024075141A1Chimeric receptor constructs for nk cellsWUGEN INC·Filed 2023·Application pending·0 cites
- 0663US2024033357A1Chimeric antigen receptors and uses thereofWUGEN INC·Filed 2023·Application pending·0 cites
- 0760US2024101668A1Polypeptides and their use in treatment of diseaseWUGEN INC·Filed 2023·Application pending·0 cites
- 0860US2023330228A1Hybrid promoters, vectors containing same and methods of useWUGEN INC·Filed 2023·Application pending·0 cites
- 0948US2020147137A1Compositions and methods for treatment of cancerWUGEN INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when WUGEN INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →